In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...

Synchron has raised $200 million to support commercialization of its brain computer interface platform, the company said Thursday. The Series D round will fund preparations to launch Synchron's ...

A patient with ALS in Australia is the first person to tweet a message to the world using only direct thought via the Stentrode™ brain computer interface NEW YORK & MELBOURNE, Australia–(BUSINESS WIRE ...